Todd A. Katz

Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials

Sebastian M. Waldstein, Christian Simader, Giovanni Staurenghi et al. · Ophthalmology · 2016 · 171 citations

Medicine, Ophthalmology, Vision Science +17

Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies

Paul Mitchell, Ian L McAllister, Michael Larsen et al. · Ophthalmology Retina · 2018 · 57 citations · Full text

Health Professions, Ophthalmology, Pharmacotherapy +17

Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies

Jean‐François Korobelnik, Chengxing Lu, Todd A. Katz et al. · Ophthalmology Retina · 2019 · 37 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +15

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS)

Jana Štefaničková, José Cunha‐Vaz, Michael Ulbig et al. · Acta Ophthalmologica · 2018 · 34 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Predictors of visual outcomes in patients with neovascular age‐related macular degeneration treated with anti‐vascular endothelial growth factor therapy: <i>post hoc</i> analysis of the <scp>VIEW</scp> studies

Paolo Lanzetta, Alan F. Cruess, Salomon Y. Cohen et al. · Acta Ophthalmologica · 2018 · 31 citations · Full text

Medicine, Ophthalmology, Pharmacology +17